荧光分光光度法检测半乳糖化白蛋白磁性阿霉素纳米粒在大鼠体内分布的研究

目的观察由半乳糖化白蛋白磁性纳米粒运载的阿霉素经舌静脉给药后在大鼠体内的的分布状况.方法全部大鼠随机分为四组,经舌静脉,按分组分别注射相应药物,剂量均为阿霉素2.5 mg/kg体重.取全血、心、肺、肝、脾、肾.全血制成血浆,器官组织制成匀浆,盐酸乙醇法提取阿霉素,用荧光光度计测量.结果静脉注射同等剂量、不同剂型的阿霉素药物后,阿霉素在器官中的蓄积程度从高到低:肝:D靶肝＞D非靶肝、C＞B＞A;心脏、肾、血浆:A＞B＞D、C;脾:B＞A、C、D;肺:B＞A＞C、D.磁性阿霉素白蛋白纳米粒注入体内后,在心、肺、肝、脾、肾中的药物浓度在15～30min达峰值,而半乳糖化后,阿霉素的药物峰值提前到5 min或之前.外加磁场和未加磁场的半乳糖化白蛋白磁性阿霉素纳米粒组的药物靶向指数和药物选择指数是均高于磁性白蛋白纳米粒.结论磁性阿霉素白蛋白纳米粒经半乳糖化后,可显著增强阿霉素对肝脏的靶向性,并显著降低心、肺、脾、肾、血浆肝外器官的组织阿霉素浓度.利用外加磁场,可提高阿霉素在肝脏特定部位蓄积的能力.因此,静脉注射半乳糖化白蛋白磁性阿霉素纳米粒是可行的.     

12例Dandy—Walker综合征的临床CT与MRI分析

目的分析Dandy—Walker综合征的临床及cT与MR!影像特征。方法采用cT与MRI常规扫描，对12例Dandy—Walker综合征的临床表现、CT与MRI征象进行回顾性分析；结果12例Dandy—Walker综合征的CT与MRI表现归纳为①小脑蚓部缺失，小脑半球发育不良、完全分离，分离的小脑半球可以不对称；②第四脑室呈囊状、扇形、三角形显著扩张或后颅窝巨大囊状阴影与第四脑室相通；③窦汇异常抬高，越过人字缝／天幕抬高；④幕上脑室对称性扩张，脑积水。结论对Dandy—Walker综合征的诊断，CT扫描能够显示后颅凹及天幕上下脑的形态与结构，其CT表现具特征性；MRI可多平面扫描，无骨质伪影，显示后颅凹优于CT，在矢状面上可显示小脑、第四脑室、导水管、后颅凹囊肿以及与天幕的关系。CT与MRI扫描对Dandy—Walker综合征能够做出定性诊断，是术前诊断的主要依据，检查无痛苦，有重要的诊断和鉴别诊断价值。     

Pressure distribution and perceived comfort in casual footwear

The aim of this investigation was to establish the relationship between short-term perceived comfort and pressure distribution on the dorsal and plantar surfaces of the foot, while walking in a range of commercially available casual footwear. The study was carried out in the biomechanics laboratory of Manchester Metropolitan University using 15 male subjects without foot pathology. Perceived upper and plantar comfort were measured using a specially designed questionnaire, while dorsal and plantar pressure distributions were measured using a rectangular sensor pad recording at 30 Hz and a Mikro-EMED insole recording at 100 Hz respectively. Analysis of variance tests were used to determine differences in perceived comfort and pressure distribution between three pairs of shoes. The findings of this study suggest that an increase in total plantar force and force-time integral may relate to a decrease in perceived plantar comfort. For the three shoes examined in this study, overall peak plantar pressure, the pressure-time integral, and total plantar area did not appear to be linked to perceived plantar comfort. Findings for the shoe upper indicate that decreased dorsal forces and pressures may be related to decreased upper comfort. These findings suggest that the measurement of pressure distribution at the foot-shoe interface could be a useful tool in identifying the causes of discomfort in footwear.     

~(125)Ⅰ眼镜蛇毒及抗眼镜蛇毒血清在小白鼠体内分布的比较观察

用氯胺-T法125I标记眼镜蛇毒示踪液及抗眼镜蛇毒血清。小白鼠分二组，用125I-眼镜蛇毒、125I-抗眼镜蛇毒血清分别给小白鼠尾静脉注射，于注射后的不同时间测定血、颈部肌肉、肝、肺、肾、心等脏器放射性分布。结果发现：125I-眼镜蛇毒在肌肉及肝、肺等器官中于注射后2小时过高峰，在肾脏中浓度高，在脑未见放射性分布，抗眼镜蛇毒血清与眼镜蛇毒分布相似但在肌肉及肺脏有更高的分布。证明抗眼镜蛇毒血清能跟踪分布眼镜蛇毒。     

氨茶碱治疗病态窦房结综合征患者的观察与护理

采用氨茶碱治疗病态窦房结综合征３０例，近期有效率为８７．０％，远期有效率（１０个月）为７４．１％。护理重点：①按时按量用药；②保证足够的用药时间；③密切监测血中氨茶碱浓度；④加强药物副反应的观察；⑤定期心电监测，严密观察病情，做好心理护理。     

肾综合征出血热地鼠肾细胞Ⅱ型灭活疫苗的安全性、免疫性及其流行病学效果考核

目的：考核HFRS地鼠肾细胞Ⅱ型灭活疫苗的安全性、免疫法及其流行病学效果。方法：采用间接免疫荧光抗体试验（IFA）、微量细胞变性中和试验（MCPENT），检测接种者血中荧光抗体及中和抗体水平；调查接种组与对照组发病情况。结果：以怀宁、广德两县18个村为疫苗观察现场，接种组7499人，对照组7261人，中强反应率为224％（5／223）。3针全程免疫后中和抗体阳转率为63．33％（19／30），荧光抗体阳转率为38.58％（27／70）；接种后1年内接种组无发病，对照组发病3例。结论：该疫苗的安全性较好；有一定水平的免疫应答，但防病效果应进一步观察确证。     

Congenital cardiac malformations in Adams-Oliver syndrome

Whole genomic hprt clones were used in Southern analysis to screen the integrity of the hprt gene in a family that includes a patient with HPRT enzyme deficiency causal to Lesch-Nyhan syndrome. A 5 kb DNA sequence deletion was found to have its endpoints in the first and third introns. The probes identified the carrier status of female family members, aided by an RFLP carried by the mother's normal X-chromosome.     

蝮蛇抗栓酶与肝素抗凝治疗小儿肾病的疗效比较

本文对60例小儿肾病患儿随机分为3组,蝮蛇抗栓酶治疗组,肝素治疗组,常规治疗组(对照组),结果总有效率分别为95％,90％,60％。蝮蛇抗栓酶组与对照组比较,差异有极显著性(P<0.01),肝素组与对照组比较,差异有显著性(P<0.05)。结果提示抗凝治疗对小儿肾病高凝状态有明显改善作用,能增加临床疗效。蝮蛇抗栓酶抗凝效果优于肝素。     

不同剂量辛伐他汀对肾病综合征高脂血症的近期疗效

目的 :观察辛伐地他汀 -舒降之对肾病综合征高脂血症的近期疗效及安全性 ,比较不同剂量辛伐他汀的降脂作用。方法 :72例均系肾综合并高脂血症的患者 ,随机分治疗组 (5 6例 )和对照组 (16例 ) ,在积极治疗原发病的同时 ,治疗组给予服辛伐他汀每晚 5～ 2 0mg ,14例混合性高脂血症患者同时服用非诺贝特 ;对照组未用降脂药。观察治疗前及治疗后 1周、2周血脂全套 (TC ,TG ,LDL和HDL)、肝功能 (AST ,ALT ,TP和ALB)、肾功能 (BUN ,Scr)、及尿蛋白定量的变化。结果 :辛伐他汀每晚 2 0mg服用 1周可使 6 3%的患者总胆固醇 (TC)下降 33% ,服用 2周可使 84%的患者血TC降至正常 ;单用辛伐他汀在降低TC的同时 ,可使甘油三酯 (TC)下降 43.16 % ,若与非诺贝特合用可使TG下降达 6 4.2 2 % ,未见不良反应发生 ;辛伐他汀的降脂作用与剂量及用药时间密切相关 ,2 0mg >10mg >5mg ,每晚服用 5mg共 2周仅能使 6 0 %的患者TC下降 12 .5 %。结论 :辛伐他汀 (每晚 2 0mg)能安全、快速有效降低肾病综合征患者的高脂血症 ,而对减少尿蛋白、改善肾功能近期无作用     

Reflection on the geographic distribution of multiple sclerosis in France

The geographic distribution of multiple sclerosis within the 95 Départements and the 21 Régions of France was defined from a 1986 nationwide prevalence series derived from questionnaires. This indicated a significant clustering of high frequency regions in the northeastern part of the country with most significantly low areas in the south and west. Distributions were similar to those for MS death rates by Département and Région for 1968–1977, indicating geographic stability over time; but there was also evidence of diffusion over time. The 1986 prevalence distribution was also compared with all published prevalence rates for communities of France. From all these resources we conclude that all of France falls within the "high frequency zone" for MS, that the nationwide prevalence rate is at least 50 per 100000 population, and that there is evidence of geographic clustering of the disease with temporal spread of the cluster.